Association Between FGFR2 (rs2981582, Rs2420946 and Rs2981578) Polymorphism and Breast Cancer Susceptibility: a Meta-analysis

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Dec 15

PMID 27966449

Citations 8

Authors

Yafei Zhang

Xianling Zeng

Pengdi Liu

Ruofeng Hong

Hongwei Lu

Hong Ji

Le Lu

Yiming Li

Affiliations

Soon will be listed here.

Abstract

The association between fibroblast growth factor receptor 2 (FGFR2) polymorphism and breast cancer (BC) susceptibility remains inconclusive. The purpose of this systematic review was to evaluate the relationship between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and BC risk. PubMed, Web of science and the Cochrane Library databases were searched before October 11, 2015 to identify relevant studies. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to estimate the strength of associations. Sensitivity and subgroup analyses were conducted. Thirty-five studies published from 2007 to 2015 were included in this meta-analysis. The pooled results showed that there was significant association between all the 3 variants and BC risk in any genetic model. Subgroup analysis was performed on rs2981582 and rs2420946 by ethnicity and Source of controls, the effects remained in Asians, Caucasians, population-based and hospital-based groups. We did not carryout subgroup analysis on rs2981578 for the variant included only 3 articles. This meta-analysis of case-control studies provides strong evidence that FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphisms were significantly associated with the BC risk. For rs2981582 and rs2420946, the association remained significant in Asians, Caucasians, general populations and hospital populations. However, further large scale multicenter epidemiological studies are warranted to confirm this finding and the molecular mechanism for the association need to be elucidated further.

Citing Articles

Investigating FGFR2 gene as a blood-based epigenetic biomarker in gastric cancer.

Aleyasin S, Moradi A, Abolhasani N, Abdollahi M Mol Biol Rep. 2024; 51(1):253.

PMID: 38302798 DOI: 10.1007/s11033-023-09082-0.

FGFR2 genetic variants in women with breast cancer.

Dix-Peek T, Dickens C, Augustine T, Phakathi B, Van Den Berg E, Joffe M Mol Med Rep. 2023; 28(6).

PMID: 37830168 PMC: 10619128. DOI: 10.3892/mmr.2023.13113.

COL1A1 and FGFR2 Single-Nucleotide Polymorphisms Found in Class II and Class III Skeletal Malocclusions in Javanese Population.

Aju Wahju Ardani I, Budipramana M, Rachmawati E, Nugraha A, Ardana I, Budhy T Eur J Dent. 2022; 17(1):183-190.

PMID: 35672017 PMC: 9949934. DOI: 10.1055/s-0042-1744371.

Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer.

Francavilla C, OBrien C Open Biol. 2022; 12(2):210373.

PMID: 35193394 PMC: 8864352. DOI: 10.1098/rsob.210373.

MassARRAY-based single nucleotide polymorphism analysis in breast cancer of north Indian population.

Bakshi D, Nagpal A, Sharma V, Sharma I, Shah R, Sharma B BMC Cancer. 2020; 20(1):861.

PMID: 32894086 PMC: 7487711. DOI: 10.1186/s12885-020-07361-8.

References

Chen F, Lu M, Lv M, Xue Y, Zhou J, Hu F . Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality. Immunogenetics. 2011; 64(1):71-6. DOI: 10.1007/s00251-011-0564-2. View

Zhang J, Qiu L, Wang Z, Leaw S, Wang B, Wang J . Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010; 124(2):419-24. DOI: 10.1007/s10549-010-0846-7. View

Slattery M, John E, Stern M, Herrick J, Lundgreen A, Giuliano A . Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study. Breast Cancer Res Treat. 2013; 140(3):587-601. PMC: 3860319. DOI: 10.1007/s10549-013-2644-5. View

Dai J, Hu Z, Jiang Y, Shen H, Dong J, Ma H . Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women. Breast Cancer Res. 2012; 14(1):R17. PMC: 3496134. DOI: 10.1186/bcr3101. View

Begg C, Mazumdar M . Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50(4):1088-101. View

McInerney N, Colleran G, Rowan A, Walther A, Barclay E, Spain S . Low penetrance breast cancer predisposition SNPs are site specific. Breast Cancer Res Treat. 2008; 117(1):151-9. DOI: 10.1007/s10549-008-0235-7. View

Gorodnova T, Kuligina E, Yanus G, Katanugina A, Abysheva S, Togo A . Distribution of FGFR2, TNRC9, MAP3K1, LSP1, and 8q24 alleles in genetically enriched breast cancer patients versus elderly tumor-free women. Cancer Genet Cytogenet. 2010; 199(1):69-72. DOI: 10.1016/j.cancergencyto.2010.01.020. View

Ozgoz A, Samli H, Hekimler Ozturk K, Orhan B, Mutlu Icduygu F, Aktepe F . An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer. J Cancer Res Ther. 2013; 9(3):370-5. DOI: 10.4103/0973-1482.114434. View

Liang H, Yang X, Chen L, Li H, Zhu A, Sun M . Heterogeneity of Breast Cancer Associations with Common Genetic Variants in FGFR2 according to the Intrinsic Subtypes in Southern Han Chinese Women. Biomed Res Int. 2015; 2015:626948. PMC: 4573424. DOI: 10.1155/2015/626948. View

10.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

11.

Xia P, Li B, Geng T, Deng Z, Dang C, Chang D . FGFR2 gene polymorphisms are associated with breast cancer risk in the Han Chinese population. Am J Cancer Res. 2015; 5(5):1854-61. PMC: 4497451. View

12.

Tamimi R, Lagiou P, Czene K, Liu J, Ekbom A, Hsieh C . Birth weight, breast cancer susceptibility loci, and breast cancer risk. Cancer Causes Control. 2010; 21(5):689-96. DOI: 10.1007/s10552-009-9496-7. View

13.

Ren L, Zhang B, Cao X, Chen Y, Ge J . [Association of FGFR2 gene polymorphism with estrogen receptor positive breast cancer detected by fluorescent quantitative PCR]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010; 27(4):445-8. DOI: 10.3760/cma.j.issn.1003-9406.2010.04.019. View

14.

Antoniou A, Spurdle A, Sinilnikova O, Healey S, Pooley K, Schmutzler R . Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet. 2008; 82(4):937-48. PMC: 2427217. DOI: 10.1016/j.ajhg.2008.02.008. View

15.

Campa D, Kaaks R, Le Marchand L, Haiman C, Travis R, Berg C . Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst. 2011; 103(16):1252-63. PMC: 3156803. DOI: 10.1093/jnci/djr265. View

16.

Butt S, Harlid S, Borgquist S, Ivarsson M, Landberg G, Dillner J . Genetic predisposition, parity, age at first childbirth and risk for breast cancer. BMC Res Notes. 2012; 5:414. PMC: 3439270. DOI: 10.1186/1756-0500-5-414. View

17.

Hunter D, Kraft P, Jacobs K, Cox D, Yeager M, Hankinson S . A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007; 39(7):870-4. PMC: 3493132. DOI: 10.1038/ng2075. View

18.

Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson D . Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet. 2008; 4(4):e1000054. PMC: 2291027. DOI: 10.1371/journal.pgen.1000054. View

19.

Peng S, Lu B, Ruan W, Zhu Y, Sheng H, Lai M . Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. Breast Cancer Res Treat. 2011; 127(2):309-24. DOI: 10.1007/s10549-011-1459-5. View

20.

Campa D, Barrdahl M, Gaudet M, Black A, Chanock S, Diver W . Genetic risk variants associated with in situ breast cancer. Breast Cancer Res. 2015; 17:82. PMC: 4487950. DOI: 10.1186/s13058-015-0596-x. View